EBLN1 Activators
EBLN1 activators are a category of chemical compounds that interact with and modulate the activity of the entity known as EBLN1, which is a shorthand for endogenous B-like neutralizing antigen 1. The activators in this class are characterized by their ability to bind to EBLN1 and influence its activity within a biological system. EBLN1 itself is a component that may be implicated in various intracellular processes, although the full extent and nature of its role remain the subject of ongoing research. The chemical structures of EBLN1 activators are diverse, with each activator possessing specific physicochemical properties that determine its affinity and specificity towards EBLN1. These properties include molecular weight, solubility, polarity, and the presence of particular functional groups that can interact with EBLN1's active sites or allosteric sites.
The interactions between EBLN1 activators and EBLN1 are governed by the principles of molecular recognition, which is a fundamental concept in biochemistry involving the binding of a molecule to a specific site on a target. This binding process is typically reversible and can be influenced by a variety of intramolecular and intermolecular forces, such as hydrogen bonding, hydrophobic effects, van der Waals forces, and electrostatic interactions. The specificity of EBLN1 activators is crucial, as it determines the selectivity of these compounds for EBLN1 over other potential binding partners within the cellular milieu. Researchers can study the binding kinetics and dynamics of EBLN1 activators to understand how these compounds interact with EBLN1 at a molecular level. Such studies often involve the use of various analytical techniques, including spectroscopy, calorimetry, and X-ray crystallography, to elucidate the structural and energetic aspects of the activator-EBLN1 interaction. The deeper understanding of these interactions contributes to the broader field of chemical biology, where the focus is on elucidating the chemical basis of biological phenomena.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, which can lead to the activation of PKA. PKA can phosphorylate various substrates that may enhance the functional activity of EBLN1 by affecting signaling pathways or cellular processes that EBLN1 is involved in. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent signaling pathways. This increase in calcium may enhance EBLN1 activity if EBLN1 is part of or regulated by calcium-dependent processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that modulates protein kinase C pathways. PKC pathways are involved in a variety of cellular processes, and if EBLN1 is part of these processes, its activity could be enhanced indirectly through PMA's action. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea that inhibits certain protein kinases. By inhibiting competitive kinase signaling, EGCG may enhance EBLN1 activity if EBLN1 is regulated by or interacts with these kinases. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/AKT signaling pathway. If EBLN1's activity is modulated through this pathway, the inhibition of PI3K could lead to an increase in EBLN1's function. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP can activate cAMP-dependent pathways, potentially enhancing EBLN1's activity by mimicking the action of endogenous cAMP where EBLN1 is regulated by cAMP-responsive elements. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which could shift the signaling equilibrium in favor of pathways where EBLN1 is active. If EBLN1 is indirectly regulated by the MAPK pathway, U0126 may enhance its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance EBLN1 activity if EBLN1 is involved in cellular processes or signaling pathways that are negatively regulated by p38 MAPK. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is another cAMP analog that activates cAMP-dependent protein kinase A (PKA). If EBLN1 activity is modulated by PKA or cAMP-responsive elements, db-cAMP can enhance the activity of EBLN1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that selectively increases intracellular calcium levels, thus potentially enhancing EBLN1 activity by activating downstream calcium-dependent signaling mechanisms if EBLN1 is involved in these pathways. | ||||||